Biomerica, Inc. (BMRA)

NASDAQ: BMRA · IEX Real-Time Price · USD
4.17
+0.10 (2.46%)
Nov 25, 2022 4:00 PM EDT - Market closed
2.46%
Market Cap 54.65M
Revenue (ttm) 19.25M
Net Income (ttm) -5.06M
Shares Out 13.10M
EPS (ttm) -0.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 21,102
Open 4.06
Previous Close 4.07
Day's Range 4.02 - 4.17
52-Week Range 2.56 - 5.25
Beta -0.53
Analysts Buy
Price Target 13.26 (+218.0%)
Earnings Date Jan 11, 2023

About BMRA

Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely... [Read more]

Industry Health Care Equipment & Supplies
Founded 1971
Employees 64
Stock Exchange NASDAQ
Ticker Symbol BMRA
Full Company Profile

Financial Performance

In 2022, Biomerica's revenue was $18.87 million, an increase of 162.14% compared to the previous year's $7.20 million. Losses were -$4.53 million, -39.15% less than in 2021.

Financial Statements

Analyst Forecast

According to 7 analysts, the average rating for BMRA stock is "Buy." The 12-month stock price forecast is 13.26, which is an increase of 217.99% from the latest price.

Price Target
$13.26
(217.99% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Biomerica InFoods® IBS Data Presented at the 2022 American College of Gastroenterology (ACG) Annual Scientific Meeting

IRVINE, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) announced that data derived from a clinical study of InFoods® IBS was presented at the 2022 American Coll...

3 weeks ago - GlobeNewsWire

Biomerica (BMRA) Stock Gets Boost From Walmart Sales Expansion

Like a turbulent airplane ride, Biomerica (NASDAQ: BMRA ) suffered a seesaw over recent sessions. Initially, BMRA stock skyrocketed on Friday morning on news that Walmart (NYSE: WMT ) will sell the unde...

1 month ago - InvestorPlace

Biomerica stock leaps as Walmart expands sales of Aware Breast Self Exam to its stores

Shares of Biomerica Inc. BMRA, +7.58% shot up 13.1% toward a 6-month high in active morning trading Friday, after the medical diagnostic products company said Walmart Inc. WMT, +0.45% will start selling...

1 month ago - Market Watch

Walmart to Expand Sales of Biomerica's Aware® Breast Self Exam; Product will now be available in over 2400 Walmart st...

IRVINE, Calif., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that under a General Merchandise Supplier Agreement with Walmart, the Company's Aware® Br...

1 month ago - GlobeNewsWire

Biomerica Reports 30% Increase in Revenues for Fiscal Q1 2023 vs. Fiscal Q1 2022

IRVINE, Calif., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today reported net sales for the three months ended August 31, 2022 of $...

1 month ago - GlobeNewsWire

Biomerica Plans Launch of InFoods® IBS Test; Names Robert Carlson as Chief Commercial Officer

IRVINE, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced plans to launch its InFoods® IBS test before calendar year end. The test will be performe...

2 months ago - GlobeNewsWire

Biomerica Reports Fiscal 2022 Year End Results

IRVINE, Calif., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its fiscal 2022 financial results.

2 months ago - GlobeNewsWire

Walmart to Start Selling Biomerica's Aware Breast Self Exam Devices

Biomerica Inc (NASDAQ: BMRA) announced that its Aware Breast Self Exam device will now be sold in Walmart Inc's (NYSE: WMT) retail system.  The Biomerica FDA-cleared Aware Breast Self Exam device is a w...

4 months ago - Benzinga

Walmart to Begin Selling Biomerica's Aware® Breast Self Exam

IRVINE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that under a General Merchandise Supplier Agreement with Walmart, the Company's Aware ® B...

4 months ago - GlobeNewsWire

Biomerica to Participate at BTIG Biotech Conference

IRVINE, Calif., June 23, 2022 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that the Company's CEO will participate at the 2022 BTIG Biotechnology Conference being held in person in ...

5 months ago - GlobeNewsWire

Biomerica Announces CE Mark for Its H. pylori Diagnostic Test, hp+detect™

- Attaining CE Mark is a major step toward commercialization –

6 months ago - GlobeNewsWire

Biomerica Announces FDA Submission For a Test to Detect Helicobacter pylori (H. pylori), a Bacteria That Infects Appr...

Gastric cancer is the third most common cause of cancer related death in the world and over 80% of gastric cancers are attributed to H. pylori bacterial infection

7 months ago - GlobeNewsWire

Biomerica Reports 111% Increase in Q3 Fiscal 2022 Revenues to $7.6 million vs. Q3 Fiscal 2021

IRVINE, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical diagnostic and therapeutic products, today announced its fiscal third quarter and...

7 months ago - GlobeNewsWire

Biomerica Announces Positive Topline Results from the Endpoint Clinical Trial of its InFoods® IBS Treatment for Patie...

IRVINE, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced positive topline results from the endpoint clinical trial of its InFoods® IBS diagnostic-...

9 months ago - GlobeNewsWire

Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021

IRVINE, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its second quarter fiscal 2022 financial ...

10 months ago - GlobeNewsWire

Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million

IRVINE, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced certain preliminary financial results for the second fiscal quarter ended November 30, 20...

11 months ago - GlobeNewsWire

Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening

IRVINE, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that Dr. Brooks Cash, one the nation's most recognized leaders in Gastroenterology medicine, has agreed to...

1 year ago - GlobeNewsWire

Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS)...

IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today announced that the Canadian Patent Office has issued a notice of allowance for Biomerica's patent application perta...

1 year ago - GlobeNewsWire

Biomerica Launches New Website for Its Aware® Breast Exam Device

IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that in conjunction with Breast Cancer Awareness month, which takes place each October, ...

1 year ago - GlobeNewsWire

Recap: Biomerica Q1 Earnings

Biomerica(NASDAQ:BMRA) stock rose by 2.53% on Monday after the company reported its Q1 earnings results on Friday, October 15, 2021 at 06:30 AM. Here's what investors need to know about the announcement.

1 year ago - Benzinga

Walmart to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Screening Test

IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that Walmart has begun in-store sales and rollout of the Company's EZ Detect™ colorectal ...

1 year ago - GlobeNewsWire

Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021

IRVINE, Calif., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its first quarter fiscal 2022 financial r...

1 year ago - GlobeNewsWire

Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think Are Ready to Pop

According to Fintel, here are five short squeeze stocks that are among the most likely to see a squeeze attempt moving forward. The post Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think...

Other symbols: ATER
1 year ago - InvestorPlace

5 Short Squeeze Candidates To Watch: Aterian, Marin On List Again, Plus 3 New Small-Cap Medical Plays

Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC), two stocks that attracted s...

Other symbols: ATERMRIN
1 year ago - Benzinga

BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smiling Today

Biomerica (BMRA) stock is surging higher on Friday thanks to a new deal with Walmart (WMT) concerning its EZ Detect product. The post BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smilin...

Other symbols: WMT
1 year ago - InvestorPlace